Acute changes in N-terminal pro-brain natriuretic peptide induced by dobutamine stress echocardiography

European Journal of Echocardiography

Volumn 8, Issue 4, 2007, Pages 265-274

  Karabinos, Ilias ^a   Karvouni, Evangelia ^a   Chiotinis, Nicolaos ^b   Papadopoulos, Anastasios ^a   Simeonidis, Phevos ^a   Tsolas, Orestis ^b   Katritsis, Demosthenes ^a  

^a Athens Euroclinic ^*  (Greece)

^b Central Laboratories   (Greece)

Author keywords

Brain natriuretic peptide; Dobutamine stress echocardiography

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DILTIAZEM; DOBUTAMINE; VERAPAMIL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HEART EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; STATISTICAL ANALYSIS; STRESS ECHOCARDIOGRAPHY;

ACUTE DISEASE; ADULT; AGED; BIOLOGICAL MARKERS; CORONARY ARTERIOSCLEROSIS; ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 34250825878     PISSN: 15252167     EISSN: 15322114     Source Type: Journal    
DOI: 10.1016/j.euje.2006.06.003     Document Type: Article

References (29)

1. Mantymaa P., Vuolteenaho O., Marttila M., and Ruskoaho H. Atrial stretch induces rapid increase in brain natriuretic peptide but not in atrial natriuretic peptide gene expression in vitro. Endocrinology 133 (1993) 1470-1473
2. Bay M., Kirk V., Parner J., Hassager C., Nielsen H., Krogsgaard K., et al. NT-proBNP: a new diagnostic screening tool to differentiate between patients with normal and reduced left ventricular systolic function. Heart 89 (2003) 150-154
3. Anand I.S., Fisher L.D., Chiang Y.T., Latini R., Masson S., Maggioni A.P., et al. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107 (2003) 1278-1283
4. Hartmann F., Packer M., Coats A.J., Fowler M.B., Krum H., Mohacsi P., et al. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 110 13 (2004) 1780-1786
5. Suzuki S., Yoshimura M., Nakayama M., Mizuno Y., Harada E., Ito T., et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation 110 (2004) 1387-1391
6. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
7. Heeschen C., Hamm C.W., Mitrovic V., Lantelme N.H., White H.D., and Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110 (2004) 3206-3212
8. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
9. Bibbins-Domingo K., Ansari M., Schiller N.B., Massie B., and Whooley M.A. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the heart and soul study. Circulation 108 (2003) 2987-2992
10. Weber M., Dill T., Arnold R., Rau M., Ekinci O., Muller K.D., et al. N-terminal B-type natriuretic peptide predicts extent of coronary artery disease and ischemia in patients with stable angina pectoris. Am Heart J 148 (2004) 612-620
11. Sabatine M.S., Morrow D.A., de Lemos J.A., Omland T., Desai M.Y., Tanasijevic M., et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 44 (2004) 1988-1995
12. Foote R.S., Pearlman J.D., Siegel A.H., and Yeo K.T. Detection of exercise-induced ischemia by changes in B-type natriuretic peptides. J Am Coll Cardiol 44 (2004) 1980-1987
13. Becher H., Chambers J., Fox K., Jones R., Leech G.J., Masani N., et al. BSE procedure guidelines for the clinical application of stress echocardiography, recommendations for performance and interpretation of stress echocardiography: a report of the British Society of Echocardiography Policy Committee. Heart 90 Suppl. 6 (2004) vi23-vi30
14. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
15. Pellikka P.A., Roger V.L., Oh J.K., Miller F.A., Seward J.B., and Tajik A.J. Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. Mayo Clin Proc 70 (1995) 16-27
16. Grossman W., Jones D., and McLaurin L.P. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56 (1975) 56-64
17. Secknus M.A., and Marwick Th. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3011 studies over 5 years. J Am Coll Cardiol 29 6 (1997) 1234-1240
18. Katritsis D.G., Karabinos I., Papadopoulos A., Simeonidis P., Korovesis S., Giazitzoglou E., et al. Sustained ventricular tachycardia induced by dobutamine stress echocardiography: a prospective study. Europace 7 (2005) 433-439
19. Marumoto K., Hamada M., and Hiwada K. Increased secretion of atrial and brain natriuretic peptides during acute myocardial ischaemia by dynamic exercise in patients with angina pectoris. Clin Sci 88 (1995) 551-556
20. Wijbenga J.A., Balk A.H., Boomsma F., Man in 't Veld A.J., and Hall C. Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice. Eur Heart J 20 (1999) 1424-1428
21. Lainchbury J.G., Campbell E., Frampton C.M., Yandle T.G., Nicholls M.G., and Richards A.M. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath. J Am Coll Cardiol 42 (2003) 728-735
22. Talwar S., Squire I.B., Downie P.F., Davies J.E., and Ng L.L. Plasma N terminal pro-brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 84 (2000) 421-424
23. Kikuta K., Yasue H., Yoshimura M., Morita E., Sumida H., Kato H., et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am Heart J 132 (1996) 101-107
24. Grabowski M., Filipiak K.J., Karpinski G., Wretowski D., Rdzanek A., Huczek Z., et al. Serum B-type natriuretic peptide levels on admission predict not only short-term death but also angiographic success of procedure in patients with acute ST-elevation myocardial infarction treated with primary angioplasty. Am Heart J 148 (2004) 655-662
25. Levin E., Gardner D., and Samson W. Natriuretic peptides. N Engl J Med 339 (1998) 321-328
26. Templeton G.H., Platt M.R., Willerson J.T., and Weisfeldt M.L. Influence of aging on left ventricular hemodynamics and stiffness in beagles. Circ Res 44 (1979) 189-194
27. Zarich S.W., Arbuckle B.E., Cohen L.R., Roberts M., and Nesto R.W. Diastolic abnormalities in young asymptomatic diabetic patients assessed by pulsed Doppler echocardiography. J Am Coll Cardiol 12 (1988) 114-120
28. Tesfamariam B., and Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263 (1992) H321-H326
29. Bhalla M.A., Chiang A., Epshteyn V.A., Kazanegra R., Bhalla V., Clopton P., et al. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol 44 (2004) 1047-1052